Phase II Clinical Trial of Etanercept Plus Extracorporeal Photopheresis GVHD Prophylaxis Following Unrelated Donor Reduced Intensity Transplant

Carrie L. Kitko; Thomas Braun; Charles Schuler; Sung Won Choi; Gregory Yanik; Attaphol Pawarode; John Magenau; Austin Taylor; James L.M. Ferrara; Daniel R. Couriel; John Levine

doi:10.1016/j.bbmt.2014.11.537

Phase II Clinical Trial of Etanercept Plus Extracorporeal Photopheresis GVHD Prophylaxis Following Unrelated Donor Reduced Intensity Transplant

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2014.11.537 ◽

2015 ◽

Vol 21 (2) ◽

pp. S337

Author(s):

Carrie L. Kitko ◽

Thomas Braun ◽

Charles Schuler ◽

Sung Won Choi ◽

Gregory Yanik ◽

...

Keyword(s):

Clinical Trial ◽

Phase Ii ◽

Phase Ii Clinical Trial ◽

Unrelated Donor ◽

Extracorporeal Photopheresis ◽

Gvhd Prophylaxis ◽

Reduced Intensity

Download Full-text

Extended CCR5 Blockade for Graft-versus-Host Disease Prophylaxis Improves Outcomes of Reduced-Intensity Unrelated Donor Hematopoietic Cell Transplantation: A Phase II Clinical Trial

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2018.09.034 ◽

2019 ◽

Vol 25 (3) ◽

pp. 515-521 ◽

Cited By ~ 8

Author(s):

Ran Reshef ◽

Alex Ganetsky ◽

Edward P. Acosta ◽

Robin Blauser ◽

Lisa Crisalli ◽

...

Keyword(s):

Clinical Trial ◽

Cell Transplantation ◽

Phase Ii ◽

Graft Versus Host Disease ◽

Hematopoietic Cell Transplantation ◽

Hematopoietic Cell ◽

Unrelated Donor ◽

Graft Versus Host ◽

Ccr5 Blockade ◽

Reduced Intensity

Download Full-text

Combination Therapy for Graft-versus-Host Disease Prophylaxis with Etanercept and Extracorporeal Photopheresis: Results of a Phase II Clinical Trial

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2015.11.002 ◽

2016 ◽

Vol 22 (5) ◽

pp. 862-868 ◽

Cited By ~ 19

Author(s):

Carrie L. Kitko ◽

Thomas Braun ◽

Daniel R. Couriel ◽

Sung W. Choi ◽

James Connelly ◽

...

Keyword(s):

Clinical Trial ◽

Combination Therapy ◽

Phase Ii ◽

Graft Versus Host Disease ◽

Phase Ii Clinical Trial ◽

Extracorporeal Photopheresis ◽

Host Disease ◽

Graft Versus Host

Download Full-text

Phase II clinical trial for the evaluation of bortezomib within the reduced intensity conditioning regimen (RIC) and post-allogeneic transplantation for high-risk myeloma patients

British Journal of Haematology ◽

10.1111/bjh.12410 ◽

2013 ◽

Vol 162 (4) ◽

pp. 474-482 ◽

Cited By ~ 27

Author(s):

Teresa Caballero-Velázquez ◽

Lucia López-Corral ◽

Cristina Encinas ◽

Cristina Castilla-Llorente ◽

Rodrigo Martino ◽

...

Keyword(s):

Clinical Trial ◽

High Risk ◽

Phase Ii ◽

Conditioning Regimen ◽

Allogeneic Transplantation ◽

Phase Ii Clinical Trial ◽

Reduced Intensity Conditioning ◽

Reduced Intensity Conditioning Regimen ◽

Reduced Intensity

Download Full-text

Potential benefits of Nigella sativa oil supplementation on asthma inflammation: a randomised, double-blind, placebo-controlled, exploratory phase-II clinical trial

Planta Medica ◽

10.1055/s-0036-1596928 ◽

2016 ◽

Vol 81 (S 01) ◽

pp. S1-S381

Author(s):

A Koshak ◽

L Wei ◽

E Koshak ◽

S Wali ◽

O Alamoudi ◽

...

Keyword(s):

Clinical Trial ◽

Phase Ii ◽

Nigella Sativa ◽

Phase Ii Clinical Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Nigella Sativa Oil ◽

Potential Benefits

Download Full-text

A result of phase II clinical trial for the dermatomycosis of new antifungus external preparation KP-363 ( butenafine hydrochloride ) cream and liquid.

Nishi Nihon Hifuka ◽

10.2336/nishinihonhifu.52.586 ◽

1990 ◽

Vol 52 (3) ◽

pp. 586-595 ◽

Cited By ~ 9

Author(s):

AKIRA OKAWARA

Keyword(s):

Clinical Trial ◽

Phase Ii ◽

Phase Ii Clinical Trial

Download Full-text

ORAL INTAKE OF PURIFIED AQUEOUS SOLUTION OF OAT ?-GLUCANS HAS NO EFFECT ON GASTRIC MUCOSA HISTOLOGICAL CHANGES IN PATIENTS WITH CHRONIC GASTRITIS: A PILOT PHASE II CLINICAL TRIAL

10.26226/morressier.57c5383cd462b80296c9c8fb ◽

2016 ◽

Author(s):

Rafal Filip

Keyword(s):

Clinical Trial ◽

Aqueous Solution ◽

Gastric Mucosa ◽

Phase Ii ◽

Chronic Gastritis ◽

Oral Intake ◽

Phase Ii Clinical Trial ◽

Pilot Phase ◽

Histological Changes

Download Full-text

Alprostadil Liposomes for Injection for Lower Extremity Arteriosclerosis Obliteran of Phase II Clinical Trial

Case Medical Research ◽

10.31525/ct1-nct04197323 ◽

2019 ◽

Author(s):

Keyword(s):

Clinical Trial ◽

Lower Extremity ◽

Phase Ii ◽

Phase Ii Clinical Trial

Download Full-text

Faculty Opinions recommendation of A phase II study of sirolimus, tacrolimus and rabbit anti-thymocyte globulin as GVHD prophylaxis after unrelated-donor PBSC transplant.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717958751.793462917 ◽

2012 ◽

Author(s):

Nelson Chao

Keyword(s):

Phase Ii ◽

Phase Ii Study ◽

Unrelated Donor ◽

Gvhd Prophylaxis

Download Full-text

Faculty Opinions recommendation of A Phase II Clinical Trial of an Aromatase Inhibitor for Postmenopausal Women with Lymphangioleiomyomatosis.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.727678658.793546414 ◽

2018 ◽

Author(s):

Jay H Ryu

Keyword(s):

Clinical Trial ◽

Aromatase Inhibitor ◽

Postmenopausal Women ◽

Phase Ii ◽

Phase Ii Clinical Trial

Download Full-text

REGOMA: A Randomized, Multicenter, Controlled Open-Label Phase II Clinical Trial of Regorafenib Compared to Lomustine in Relapsed Glioblastoma Patients

SSRN Electronic Journal ◽

10.2139/ssrn.3212963 ◽

2018 ◽

Author(s):

Giuseppe Lombardi ◽

Gian Luca De Salvo ◽

Alba Ariela Brandes ◽

Marica Eoli ◽

Roberta Rudà ◽

...

Keyword(s):

Clinical Trial ◽

Phase Ii ◽

Phase Ii Clinical Trial ◽

Open Label ◽

Open Label Phase

Download Full-text